香港股市 已收市

Shengtai Pharmaceutical, Inc. (SGTI)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
0.00000.0000 (0.00%)
市場開市。 截至 01:03PM EDT。

Shengtai Pharmaceutical, Inc.

Changda Road East
Development District Changle County
Weifang 262400
China
86 53 6218 8831

版塊
行業
全職員工

高階主管

名稱頭銜支付行使價出生年份
Mr. Qingtai LiuChairman, CEO & President19k1957
Mr. Yongqiang WangCFO, Principal Accounting Officer, Financial Controller & Director14.25k1969
截止 2010年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People's Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment. The company markets its products directly to healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies. Shengtai Pharmaceutical, Inc. was incorporated in 2004 and is based in Weifang, China.

公司管治

截至 無 止,Shengtai Pharmaceutical, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。